SF3B1 mutation predicts unfavorable treatment-free survival in Chinese chronic lymphocytic leukemia patients

BACKGROUND: Splicing factor 3b subunit 1 (SF3B1), a splicing factor modulating RNA alternative splicing, is frequently mutated in multiple hematological malignancies including myelodysplastic syndromes and chronic lymphocytic leukemia (CLL). The clinical impact of SF3B1 mutation on CLL remains contr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Miao, Yi, Zou, Yi-Xin, Gu, Dan-Ling, Zhu, Hong-Cheng, Zhu, Hua-Yuan, Wang, Li, Liang, Jin-Hua, Xia, Yi, Wu, Jia-Zhu, Shao, Chun-Lin, Fan, Lei, Zhang, Zhen, Xu, Wei, Li, Jian-Yong
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6526254/
https://ncbi.nlm.nih.gov/pubmed/31168457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.03.63
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados